New Classifications of Appendiceal Tumors and Understanding the Connection Between Appendix and Ovary: A Pathologist View
Recorded on November 10, 2010 (60 minutes)

The Seventh Edition Cancer Staging Manual incorporates some significant changes in cancer staging for specific disease sites.  The purpose of this presentation is to highlight the major changes for Appendix and Ovary and demonstrate the important connection the sites share. The presentation will focus on the new classification of appendicea ltumors and what pathologists need to know when using the new staging in the Seventh Edition Cancer Staging Manual. 


Target Audience:  This program is primarily intended for physicians, but also open to cancer registrars.

 

Learning Objectives:

1.     Understand the relationship between appendix and ovary

2.     Identify the new classification for appendix:

a.      No longer a part of the colon chapter

b.     Includes carcinomas and carcinoid

3.     Discuss the rationale for the changes

4.     Review prognostic factors 

 

 

Financial support for the development of this presentation and webinar has been provided by the American Cancer Society. The information provided here does not necessarily represent the views of the American Cancer Society, Society Staff, or it's Board of Directors. 

 

 

 

For registration support, please call 1-800-274-9390 or email facs@commpartners.com

 

If you would like to pay by check or register via telephone, please contact our Customer Support Group at 1-800-274-9390. 


The American Cancer Society has provided funding to underwrite the cost of the AJCC webinars beginning in September 2010. The new price is a reflection of their generous financial support.

Presenters:

Christopher Otis, MD
Director of Surgical Pathology
Baystate Medical Center

 

Dr. Christopher Otis is the Director of Surgical Pathology at Baystate Medical Center and Professor of Pathology at Tufts University School of Medicine. Dr. Otis received his Medical Degree from Yale University School of Medicine in 1982. At Yale University School of Medicine, he also completed his residency, held Chief Residency and completed a Fellowship in Surgical Pathology. Dr. Otis has been the recipient of numerous awards and authored over 70 peer reviewed journal articles. Dr. Otisí areas of interest include, Gynecologic Pathology Cytopathology Immunohistochemistry Molecular Pathology Tumorigenesis with emphasis on cell signaling pathways and tumor suppressor genes. Dr. Otis is an active member of several professional organizations including the Arthur Purdy Stout Society, American Society of Clinical Pathologists, College of American Pathologists, and is past president of both the Association of Directors of Anatomic and Surgical Pathology and the New England Society of Pathologists.

 

Leslie H. Sobin, MD
Co-Chair, TNM Prognostic Factors Project
International Union Against Cancer (UICC)
Geneva, Switzerland

 

Faculty Disclosures

CE Credit:  The National Cancer Registrars Association(NCRA) has determined that this program 2010-099 supports 1.0 CE Hours.

CME Credit: 

ACCREDITATION
The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medial education for physicians.

CME CREDIT
The American College of Surgeons designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits TM.  Physicians should only claim credit commensurate with the extent of their participation in the activity.
Select a Webinar Format:

You must be logged in to add a program to your cart.